ATLASiShares Genomics Immunology and Healthcare ETF (IDNA): outlook, holdings and fees
iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund and is managed by iShares. The expense ratio is 0.47% and the yield is 0.66%. The ten largest holdings are 49% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on IDNA
| Last price | $41.93 (-1.9%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 50% |
| Likely 1-month range (50%) | $39.55 – $44.53 |
| Normal 1-day range (±1σ) | ±2.0% |
| Distribution yield | 0.66% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
IDNA fund facts
| Issuer | iShares |
|---|---|
| Theme | Technology & innovation |
| Assets under management | $317M |
| Expense ratio | 0.47% |
| Number of holdings | 47 |
| Portfolio turnover | 44% |
| Inception | Jun 11, 2019 |
| Exchange | NYSE |
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-. The fund is non-diversified.
IDNA top holdings
| Holding | Sector | Weight |
|---|---|---|
| Moderna Inc MRNA | Healthcare | 13.29% |
| Twist Bioscience Corp TWST | Healthcare | 6.33% |
| Iovance Biotherapeutics Inc IOVA | Healthcare | 4.83% |
| Genmab A/S GMAB | Healthcare | 4.22% |
| Revolution Medicines Inc RVMD | Healthcare | 3.45% |
| Immunitybio Inc IBRX | Healthcare | 3.36% |
| Merck & Company Inc MRK | Healthcare | 3.34% |
| Takeda Pharmaceutical Co. Ltd. 4502 | Healthcare | 3.31% |
| Regeneron Pharmaceuticals Inc REGN | Healthcare | 3.37% |
| Bayer AG NA BAYN | Healthcare | 3.29% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
IDNA sector breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.0% |
By region: North America 74.2%, Europe Developed 16.9%, Japan 4.5%, United Kingdom 2.4%, Asia Emerging 1.8%.
IDNA returns and risk
| Year to date | +64.7% |
|---|---|
| 1 year | +71.7% |
| 3 years (annualised) | +31.0% |
| 5 years (annualised) | -1.5% |
| 10 years (annualised) | 0.0% |
| Volatility (3 years) | 25.8% |
| Sharpe ratio (3 years) | 0.97 |
Past returns do not guarantee future results.
IDNA: frequently asked questions
What does IDNA invest in?
iShares Genomics Immunology and Healthcare ETF invests in a portfolio of securities. Its largest holdings are Moderna Inc (13.3%), Twist Bioscience Corp (6.3%), Iovance Biotherapeutics Inc (4.8%), Genmab A/S (4.2%), Revolution Medicines Inc (3.5%).
What is the IDNA expense ratio?
0.47% a year: about $47.00 for every $10,000 invested.
What is the IDNA dividend yield?
0.66%. ATLAS does not hold the exact distribution dates for ETFs.
Will IDNA go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 50%, with a likely range (50%) of $39.55 to $44.53 from $41.93 today. It is a probability, not a prediction.
How has IDNA performed?
Year to date +64.7%, one year +71.7%, three years +31.0% a year, five years -1.5% a year. Past returns do not guarantee future results.
Similar ETFs: Technology & innovation
- Vanguard Information Technology ETF (VGT)
- State Street Technology Select Sector SPDR ETF (XLK)
- iShares U.S. Technology ETF (IYW)
- Fidelity MSCI Information Technology Index ETF (FTEC)
- First Trust Nasdaq Cybersecurity ETF (CIBR)
- iShares Expanded Tech-Software Sector ETF (IGV)
- iShares A.I. Innovation and Tech Active ETF (BAI)
- iShares Expanded Tech Sector ETF (IGM)
Educational information, not investment advice. Disclaimer